Round Up

Five things for pharma marketers to know: Monday, June 18, 2018

Five things for pharma marketers to know: Monday, June 18, 2018

By

Quest Analytics buys BetterDoctor; Analyst Eric Schmidt to join Allogene Therapeutics; Two-thirds of Americans "very concerned" about cost of health insurance.

Five things for pharma marketers to know: Friday, June 16, 2018

Five things for pharma marketers to know: Friday, June 16, 2018

By

Eli Lilly CEO says changes needed in drug pricing system; Kentucky sues Walgreens over opioid epidemic; Teva faces migraine drug setback.

Five things for pharma marketers to know: Thursday, June 14, 2018

Five things for pharma marketers to know: Thursday, June 14, 2018

By

BIO afterparty again sparks controversy; GSK meets goal for two-drug HIV treatment; Mylan receives complete response letter for Advair generic.

Five things for pharma marketers to know: Wednesday, June 13, 2018

Five things for pharma marketers to know: Wednesday, June 13, 2018

By

Drugmakers not dropping prices on Trump timeline; Azar backs insurance for those with preexisting conditions; Stryker denies interest in Boston Scientific takeover.

Five things for pharma marketers to know: Tuesday, June 12, 2018

Five things for pharma marketers to know: Tuesday, June 12, 2018

By

FDA puts Sage depression treatment on accelerated timeline; AstraZeneca, Lilly cease Alzheimer's treatment trial; Stryker makes offer for Boston Scientific.

Five things pharma marketers need to know: Monday, June 11, 2018

Five things pharma marketers need to know: Monday, June 11, 2018

By

Eckert returns to lead Sprout Pharmaceuticals; Sorrell denies prostitution allegation; AHIP warns about removing key Obamacare provisions.

Five things for pharma marketers to know: Friday, June 8, 2018

Five things for pharma marketers to know: Friday, June 8, 2018

By

Novo Nordisk considers cutting 3,000 jobs; Pharma companies pressured to move birth control over the counter; Gates Foundation launches a nonprofit biotech.

Five things for pharma marketers to know: Thursday, June 7, 2018

Five things for pharma marketers to know: Thursday, June 7, 2018

Bayer closes Monsanto deal after lengthy antitrust review; Bezos, Dimon, Buffett pick CEO to run healthcare venture; Novartis to avoid criminal actions over Cohen payments.

Five things for pharma marketers to know: Wednesday, June 6, 2018

Five things for pharma marketers to know: Wednesday, June 6, 2018

Athenahealth CEO steps down; Former Celgene chief executive wins New Jersey Senate primary; Big Pharma not planning campaign against Trump drug pricing plan.

Five things for pharma marketers to know: Tuesday, June 5, 2018

Five things for pharma marketers to know: Tuesday, June 5, 2018

By

Medicare Part D brand-name drug costs up even as prescriptions fall; Gottlieb could speed up approval process for competitors of first-to-market drugs; FDA approves Filphila.

Five things for pharma marketers to know: Friday, June 1, 2018

Five things for pharma marketers to know: Friday, June 1, 2018

By

Opioid prescriptions drop for fifth year in a row; AstraZeneca reprimanded by U.K. regulator; Samsung partners with Babylon to bring appointments to smartphones.

Five things for pharma marketers to know: Thursday, May 31, 2018

Five things for pharma marketers to know: Thursday, May 31, 2018

FDA approves first artificial iris; Trump expects voluntary drug price cuts; Novartis' head of oncology departs.

Five things for pharma marketers to know: Wednesday, May 30, 2018

Five things for pharma marketers to know: Wednesday, May 30, 2018

By

Allergan to sell women's and infectious disease units; Large clinical trials falling out of favor; American Cancer Society recommends earlier screening for colon cancer.

Five things for pharma marketers to know: Tuesday, May 29, 2018

Five things for pharma marketers to know: Tuesday, May 29, 2018

By

MIT researchers develop ingestible sensor to detect intestinal bleeding; Diet Madison Avenue goes dark after defamation suit filed; Justice Department report finds Purdue knew about potential for OxyContin abuse.

Five things for pharma marketers to know: Friday, May 25, 2018

Five things for pharma marketers to know: Friday, May 25, 2018

By

AstraZeneca lung cancer drug meets key goal; Johnson & Johnson loses another talc lawsuit; Cancer drugs account for 80% of drug sales.

Five things for pharma marketers to know: Thursday, May 24, 2018

Five things for pharma marketers to know: Thursday, May 24, 2018

Recro non-opioid injection receives complete response letter from FDA; Pfizer settles False Claims Act allegations; Medtronic reports better-than-expected profit.

Five things for pharma marketers to know on Wednesday, May 23, 2018

Five things for pharma marketers to know on Wednesday, May 23, 2018

Keytruda passes late-stage trial; Astellas to cut 600 jobs in restructuring; Teva expects FDA decision on migraine drug by mid-September.

Five things for pharma marketers to know: Tuesday, May 22, 2018

Five things for pharma marketers to know: Tuesday, May 22, 2018

Geisinger looks to expand DNA sequencing program; Celgene invests $65 million more in Evotec; Oscar launches transparency push.

Five things for pharma marketers to know: Monday, May 21, 2018

Five things for pharma marketers to know: Monday, May 21, 2018

By

FDA approves AstraZeneca potassium drug; Nabriva pneumonia treatment meets Phase III endpoints; "Bad Blood" hits bookshelves.

Five things for pharma marketers to know: Friday, May 18, 2018

Five things for pharma marketers to know: Friday, May 18, 2018

By

First preventative migraine treatment approved; NIH investigates funding for alcohol study; Trump to block federal funding for abortion clinics.

Five things for pharma marketers to know: Thursday, May 17, 2018

Five things for pharma marketers to know: Thursday, May 17, 2018

Biden Cancer Initiative chief gets Transforming Healthcare conference started; Former Novartis CEO on Cohen payments; J&J's Gorsky has advice for Trump on drug pricing plan.

Five things for pharma marketers to know: Wednesday, May 16, 2018

Five things for pharma marketers to know: Wednesday, May 16, 2018

By

Novartis' top lawyer exits after Cohen payments; More states file suit against Purdue Pharma; J&J to relaunch baby line.

Five things for pharma marketers to know: Tuesday, May 15, 2018

Five things for pharma marketers to know: Tuesday, May 15, 2018

By

Feds join whistleblower case against Insys; Kleiner Perkins Caufield partner Seidenberg departs; Lilly strikes second acquisition deal in a week.

Five things for pharma marketers to know: Monday, May 14, 2018

Five things for pharma marketers to know: Monday, May 14, 2018

By

Beam Therapeutics raises $87 million in Series A funding; Trump drug-pricing plan largely spares big pharma; Novartis regrets Cohen consulting pact.

Five things for pharma marketers to know: Friday, May 11, 2018

Five things for pharma marketers to know: Friday, May 11, 2018

By

Trump on drug pricing; Alexa breaks into healthcare; Merck's experimental Ebola vaccine headed to Congo outbreak.

Five things for pharma marketers to know: Thursday, May 10

Five things for pharma marketers to know: Thursday, May 10

Novartis discloses $1.2 million Cohen payment; FDA calls for two stem cell companies to halt operations; Eli Lilly to buy Armo Biosciences for $1.6 billion

Five things for pharma marketers to know: Wednesday, May 9, 2018

Five things for pharma marketers to know: Wednesday, May 9, 2018

By

Novartis payments to Trump lawyer made public; Cardinal Health apologizes for mass painkiller shipments; Valeant plans rebranding.

Five things for pharma marketers to know: Tuesday, May 8, 2018

Five things for pharma marketers to know: Tuesday, May 8, 2018

By

Takeda, Shire reach a deal; Walmart to restrict opioid prescriptions; Glaxo launches global media review.

Five things for pharma marketers to know: Monday, May 7, 2018

Five things for pharma marketers to know: Monday, May 7, 2018

By

Elliott makes offer for AthenaHealth; J&J releases data from esketamine late-stage trial; Roche wins fast Tecentriq review from FDA.

Five things for pharma marketers to know: Friday, May 4, 2018

Five things for pharma marketers to know: Friday, May 4, 2018

Daraprim retains high price tag despite Shkreli sentencing; Merck invests $125 million in Moderna; Cigna posts better-than-expected Q1 earnings.